ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
THE IMPACT OF GENERALIZED RISK ADJUSTED COST-EFFECTIVENESS ANALYSIS (GRACE) ON VALUE ASSESSMENT: FROM FORMAL ADOPTION TO GLOBAL METHODOLOGICAL TRENDS
Mar 18, 2026, 21:38 PM -
COST ANALYSIS OF LUPUS NEPHRITIS IN THE BRAZILIAN UNIFIED HEALTH SYSTEM - RWD STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS VERSUS SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION AMONG U.S. ADULTS WITH DIABETES: A MEPS-BASED ECONOMIC EVALUATION 2022
Mar 18, 2026, 21:38 PM -
US PAYER CURRENT AND FUTURE ADOPTION OF ARTIFICIAL INTELLIGENCE
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH EGFR-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
CLINICIAN TESTING OF A PREFERENCE-BASED MEASURE TO TEST SENSITIVITY AND RELEVANCE FOR UTILITIES ESTIMATION IN EARLY HD
Mar 18, 2026, 21:38 PM -
A QUALITATIVE ANALYSIS OF RECENT NEW HEALTH TECHNOLOGY ASSESSMENT CASES AND EVALUATION TRENDS FOR THE ADOPTION OF NOVEL TECHNOLOGIES
Mar 18, 2026, 21:38 PM -
STANDARDIZING AI MODEL INTERACTION WITH HEALTHCARE SYSTEMS USING THE MODEL CONTEXT PROTOCOL (MCP)
Mar 18, 2026, 21:38 PM -
COMPARATIVE CARDIOVASCULAR RISK IN U.S. POSTMENOPAUSAL WOMEN STARTING ROMOSOZUMAB VS DENOSUMAB: A HIGH-DIMENSIONAL INVERSE PROBABILITY OF SELECTION WEIGHTING ANALYSIS FOR MISSING CARDIOVASCULAR RISK FACTORS
Mar 18, 2026, 21:38 PM -
TYPE 2 COMORBIDITIES IN PATIENTS INITIATING DUPILUMAB FOR ASTHMA: REAL-WORLD EVIDENCE FROM A NATIONAL US DATABASE
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION OF EMBEDDED QUALITATIVE INTERVIEWS IN CLINICAL TRIALS: INSIGHTS FROM THE LITERATURE
Mar 18, 2026, 21:38 PM -
LEVERAGING GENERATIVE AI AND MACHINE LEARNING FOR ROBUST REAL-WORLD COHORT DEFINITION AND PATIENT JOURNEY INSIGHTS IN HIV RESEARCH
Mar 18, 2026, 21:38 PM -
APTITUDE TOWARDS PATIENT-CENTERED CARE AMONG PHYSICIANS MANAGING RARE DISEASES IN THE UNITED STATES: A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
EARLY REAL-WORLD ADHERENCE TO MRI SAFETY SURVEILLANCE AFTER LECANEMAB INITIATION AMONG MEDICARE BENEFICIARIES
Mar 18, 2026, 21:38 PM -
ORPHAN CELL AND GENE THERAPY APPROVALS IN THE US AND EUROPE: A COMPARATIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
A COST OUTCOMES ANALYSIS OF APIXABAN VERSUS RIVAROXABAN FOR THE TREATMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Mar 18, 2026, 21:38 PM -
BURDEN OF DISEASE AND PATIENT JOURNEY OF COPD IN BRAZIL: A REAL-WORLD EVIDENCE STUDY USING LINKED PUBLIC DATABASES
Mar 18, 2026, 21:38 PM